E. A. Sahin Et Al. , "Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years," POSTGRADUATE MEDICINE , vol.134, no.6, pp.635-640, 2022
Sahin, E. A. Et Al. 2022. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years. POSTGRADUATE MEDICINE , vol.134, no.6 , 635-640.
Sahin, E. A., Mavi, D., KARA, E., SÖNMEZER, M. Ç., İNKAYA, A. Ç., & ÜNAL, S., (2022). Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years. POSTGRADUATE MEDICINE , vol.134, no.6, 635-640.
Sahin, Ezgi Et Al. "Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years," POSTGRADUATE MEDICINE , vol.134, no.6, 635-640, 2022
Sahin, Ezgi A. Et Al. "Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years." POSTGRADUATE MEDICINE , vol.134, no.6, pp.635-640, 2022
Sahin, E. A. Et Al. (2022) . "Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years." POSTGRADUATE MEDICINE , vol.134, no.6, pp.635-640.
@article{article, author={Ezgi Aysu Sahin Et Al. }, title={Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years}, journal={POSTGRADUATE MEDICINE}, year=2022, pages={635-640} }